Stock listing

XE9 Stock Price, News, Filings & Events — Xencor, Inc.

Selected listing: XE9 · GETTEX · EUR · DE

The XE9:GETTEX listing represents Xencor, Inc., a biopharmaceutical company focused on developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases. Recently, Xencor has been involved in advancing its clinical programs and collaborating with other organizations to enhance its therapeutic offerings. Investors can find the latest news, regulatory filings, and upcoming events related to the company's progress and market activities on this page. The context of Xencor's innovative approach positions it within a competitive landscape in the biotechnology sector.

XE9:GETTEXEURDEUpdated July 21, 2026
Xencor, Inc. logo
Ticker
XE9:GETTEX
Asset type
Stock
Market cap
$1.30B
Sector
Health Technology
Industry
Biotechnology
Exchange
GETTEX
Currency
EUR

Xencor, Inc. XE9:GETTEX stock context

The XE9:GETTEX listing represents Xencor, Inc., a biopharmaceutical company focused on developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases. Recently, Xencor has been involved in advancing its clinical programs and collaborating with other organizations to enhance its therapeutic offerings. Investors can find the latest news, regulatory filings, and upcoming events related to the company's progress and market activities on this page. The context of Xencor's innovative approach positions it within a competitive landscape in the biotechnology sector.

Research Xencor, Inc.

Alternate listings